Skip to main content
OpenTrials
Completed

NCT Number: NCT07050017

Impact of Protein Content of Milk on Post-Exercise Appetite and Energy Intake

This study aims to investigate the acute effects of consuming milk beverages with different protein content on subjective appetite and energy intake in healthy adults following endurance exercise. Participants will complete an endurance exercise protocol and then consume one of three beverages: a high-protein milk, a regular-protein milk, or an isoenergetic and isovolumetric carbohydrate control drink. Subjective appetite ratings will be assessed using visual analogue scales (VAS) at multiple time points after beverage consumption. Appetite-related hormonal responses, including insulin and acylated ghrelin, will be measured via blood samples. Energy intake will be assessed through an ad libitum test meal. This study will help determine whether different types of milk consumed post-exercise influence appetite regulation, hormonal response, and subsequent energy intake.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–39 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Hacettepe University

Ankara, Turkey (Türkiye)

About this study

The primary objective of this randomized, double-blind, crossover clinical trial is to evaluate the acute effects of post-endurance exercise consumption of milk beverages with varying protein content on subjective appetite, circulating appetite-related hormones, and subsequent ad libitum energy intake in healthy, recreationally active adult males. The study will recruit at least 12 healthy male participants aged 18-39 years who have been regularly engaged in endurance-based physical activity (e.g., cycling, running, triathlon, orienteering, team sports) for a minimum of one year, with a training frequency of at least three sessions per week lasting 60-90 minutes each. Participants will complete five laboratory visits under a crossover design with a minimum one-week washout period between intervention conditions. The first two sessions will consist of pre-study visits (screening, anthropometric assessments, VO₂max testing, and familiarization). The remaining three visits will involve the ingestion of one of the following beverages in a randomized order: standard-protein milk (0 g protein), high-protein milk (30 g protein), or an isoenergetic carbohydrate-based control beverage (0 g protein). All beverages will be isocaloric and isovolumetric and provided in opaque bottles to ensure double-blind conditions. On each intervention day, participants will perform a steady-state endurance exercise protocol using a calibrated cycle ergometer, followed immediately by the ingestion of one of the test beverages. Appetite will be assessed subjectively using validated Visual Analogue Scales (VAS) at predefined intervals. Venous blood samples will be collected to analyze concentrations of insulin and acylated ghrelin as objective biomarkers of appetite regulation. One hour after beverage consumption, an ad libitum test meal will be provided to quantify subsequent energy intake. The total caloric intake and macronutrient distribution will be recorded and analyzed. This study is designed to provide insight into the role of post-exercise milk consumption-specifically the influence of protein content-on short-term appetite modulation and energy intake regulation in recreationally trained individuals.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The study will include healthy, physically active male participants aged 18-39 years who have been engaging in recreational endurance sports (such as cycling, running, triathlon, orienteering, or team sports) for at least one year, with a minimum frequency of 3 sessions per week lasting 60-90 minutes.

Exclusion criteria

  • Current smoker
  • Chronic or excessive alcohol consumption
  • Use of supplements and/or chronic medications that may affect appetite
  • Presence of cardiac, hepatic, renal, pulmonary, neurological, hematological, gastrointestinal, diabetic, thyroid, or psychiatric disorders, and/or musculoskeletal conditions that may limit exercise participation
  • Allergy or intolerance to any of the foods or beverages to be consumed during the study
  • Unstable body weight (e.g., weight loss greater than 1 kg in the past week)
  • Currently following a weight-loss diet
  • Diagnosed eating disorders or individuals who cognitively restrict food intake (to be assessed using the Three-Factor Eating Questionnaire)

Treatment and study plan

The study will investigate how different amounts of protein (0 g, 15 g, and 30 g) in post-exercise beverages affect appetite and energy intake following endurance exercise.

Behavioral

The study will investigate how different amounts of protein (carbohydrate control drink : 0 g, reguler milk : 15 g, and high-protein milk : 30 g) in post-exercise beverages affect appetite and energy intake following endurance exercise.

Primary outcomes

  1. energy intake

    Time frame: From enrollment to the end of treatment at 3 weeks.

    Energy intake will be measured through an ad libitum meal provided after the exercise.

Secondary outcomes

  1. acylated ghrelin (pg/mL)

    Time frame: From enrollment to the end of treatment at 3 weeks.

    Plasma acyl ghrelin will be measured as an indicator of appetite.

  2. Insulin (pmol/L)

    Time frame: From enrollment to the end of treatment at 3 weeks.

    Plasma insulin will be measured as an indicator of appetite and glucose metabolism.

  3. subjective appetite

    Time frame: From enrollment to the end of treatment at 3 weeks.

    Subjective appetite will be assessed using Visual Analogue Scales (mm).

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

High Milk Protein Content Reduces ad Libitum Post-exercise Energy Intake Without Altering Appetite in Active Males

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 3, 2025
Registry last updated
Oct 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.